Bio-Technology General Euflexxa 1% Sodium Hyaluronate

국가: 싱가포르

언어: 영어

출처: HSA (Health Sciences Authority)

제공처:

FERRING PHARMACEUTICALS PRIVATE LIMITED

수업:

Class D medical device

Manufactured by:

Bio-Technology General (Israel) Ltd.

치료 영역:

Orthopaedics

치료 징후:

EUFLEXXA is indicated for the treatment of pain caused by osteoarthritis of the knee, hip, temporomandibular, carpometacarpal, shoulder and ankle joints. EUFLEXXA aids in lubrication of the joint, allows for greater mobility and flexibility of the treated joint, and reduces pain in the affected joint.

제품 요약:

Device System Info:[Sterile Medical Device], EUFLEXXA is packed in a single-use, aseptically-filled disposable sterile 2.25 ml syringe (nominal volume) containing either 1 ml or 2 ml of 1% microbial fermentation-derived NaHA in phosphate-buffered saline; Models: Euflexxa 1% Sodium Hyaluronate - 3 x 2ml, Euflexxa 1% Sodium Hyaluronate - 1 x 2ml

승인 날짜:

2017-04-28